When we compared the clinical and pathological characteristics of carrier patients with non-carrier patients, we observed that, in BC, BRCA2 carriers were more frequently overweight, had a more marked family history of breast, ovarian, or pancreatic cancer, and showed a lower complete response rate to chemotherapy, suggesting both a hereditary influence and possible differences in treatment sensitivity. Here, BRCA2 is linked to breast cancer.